Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Genomic Imprinting and Inheritance

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

Mutation, Gene Flow, and Genetic Drift

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

What is Genetic Engineering?

What is Genetic Engineering?

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrating an Organocatalyst into a Polymeric Gel Framework for the Continuous Microflow Baylis-Hillman Reaction.

ACS omega·2026

Same author

Ingestible active capsule for gastrointestinal microbiome sampling.

Biomedical microdevices·2026

Same author

Arbuscular mycorrhizal fungal families and exploration-based guilds exhibit distinct responses to long-term N, P and K deficiencies and imbalances.

The New phytologist·2026

Same author

Microbial Nitrogen Cycling Becomes Conservative and Resilient to Long-Term Warming in High-Latitude Carbon-Limited Soils.

Global change biology·2025

Same author

Corrigendum to "Response of human periosteal cells to degradation products of zinc and its alloy" [Mater. Sci. Eng. C 108 (2020) 110208].

Biomaterials advances·2025

Same author

Developing a Lifetime Cost Calculator for Spinal Cord Injury: The SCI Cost Calculator.

Global spine journal·2025

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Endogenous information, adverse selection, and prevention: Implications for genetic testing policy.

Richard Peter¹, Andreas Richter², Paul Thistle³

¹Department of Finance, University of Iowa, United States.

Journal of Health Economics

|August 5, 2017

Summary

Genetic testing provides decision-making value but introduces classification risk for insurance. A duty to disclose genetic information is the preferred policy, outperforming an information ban.

Keywords:

Adverse selection Information value Insurance Moral hazard Prevention

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: Feb 25, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

Health Economics
Insurance Markets
Genetic Information Policy

Background:

Insurance markets face moral hazard and adverse selection due to unobservable individual prevention efforts.
Individuals have access to various prevention technologies, influencing health outcomes.
Genetic testing offers information about individual prevention technology effectiveness.

Purpose of the Study:

To analyze public policy regarding insurers' use of genetic information.
To determine the value of genetic information under different policy regimes.
To assess equilibrium outcomes in insurance markets based on genetic information policies.

Main Methods:

Economic modeling of insurance markets with asymmetric information.
Analysis of individual decision-making regarding genetic testing and behavior adjustment.
Comparison of four distinct public policy regimes for genetic information.

Main Results:

Genetic testing has decision-making value but creates classification risk, reducing its overall value.
Different policy regimes yield varying equilibrium outcomes in the insurance market.
Policy regimes can be Pareto ranked based on their impact.

Conclusions:

A duty to disclose genetic information is the most preferred policy regime.
An information ban regarding genetic information is the least preferred policy.
Policy design significantly impacts the value of genetic information and insurance market efficiency.